71 related articles for article (PubMed ID: 19961800)
1. [Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.].
Yan XF; Xu Y; Zheng J; Lai BC; Wang YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1133-5. PubMed ID: 19961800
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein.
Cho HJ; Hahm MS; Kim MK; Han IK; Jung WW; Choi HG; Kim JA; Oh YK
Protein Pept Lett; 2007; 14(5):417-24. PubMed ID: 17584165
[TBL] [Abstract][Full Text] [Related]
3. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
[TBL] [Abstract][Full Text] [Related]
4. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.
Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND
Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603
[TBL] [Abstract][Full Text] [Related]
5. Mapping the B cell epitopes within the major capsid protein L1 of human papillomavirus type 16.
Wang A; Li N; Zhou J; Chen Y; Jiang M; Qi Y; Liu H; Liu Y; Liu D; Zhao J; Wang Y; Zhang G
Int J Biol Macromol; 2018 Oct; 118(Pt A):1354-1361. PubMed ID: 29959021
[TBL] [Abstract][Full Text] [Related]
6. Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies.
Kulski JK; Sadleir JW; Kelsall SR; Cicchini MS; Shellam G; Peng SW; Qi YM; Galloway DA; Zhou J; Frazer IH
Virology; 1998 Apr; 243(2):275-82. PubMed ID: 9568027
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
8. Immune response to plasmid DNA encoding HPV16-L1 protein.
Sun X; Si L; Cao Z; Wang Y; Liu T; Guo J
Chin Med J (Engl); 2000 Mar; 113(3):277-80. PubMed ID: 11775264
[TBL] [Abstract][Full Text] [Related]
9. [Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum].
Tian H; Han L; Ren J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):317-20. PubMed ID: 11986714
[TBL] [Abstract][Full Text] [Related]
10. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
[TBL] [Abstract][Full Text] [Related]
11. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
Kim SN; Jeong HS; Park SN; Kim HJ
J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
[TBL] [Abstract][Full Text] [Related]
12. Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
Wang X; Wang Z; Christensen ND; Dillner J
Virology; 2003 Jun; 311(1):213-21. PubMed ID: 12832218
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
[TBL] [Abstract][Full Text] [Related]
15. HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice.
Berg M; Gambhira R; Siracusa M; Hoiczyk E; Roden R; Ketner G
Vaccine; 2007 Apr; 25(17):3501-10. PubMed ID: 16914239
[TBL] [Abstract][Full Text] [Related]
16. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.
Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB
Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404
[TBL] [Abstract][Full Text] [Related]
19. Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein.
Wang Y; Shang Q; Xu W; Li D; Gu H; Wei L
Diagn Pathol; 2014 May; 9():101. PubMed ID: 24884993
[TBL] [Abstract][Full Text] [Related]
20. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
